Lifelong Relapse Prevention with Antipsychotics in Schizophrenia

被引：1
|
作者：
Hasan, Alkomiet [1 ]
Wobrock, Thomas [1 ]
机构：
[1] Univ Med Gottingen, Zentrum Psychosoziale Med, Abt Psychiat & Psychotherapie, D-37075 Gottingen, Germany
来源：
PSYCHIATRISCHE PRAXIS | 2010年 / 37卷 / 06期
关键词：
WITHDRAWAL; METAANALYSIS; DRUGS; RISK;
D O I：
10.1055/s-0030-1248517
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
[No abstract available]
引用
收藏
页码：268 / 270
页数：3
相关论文
共 50 条
  • [1] Mean doses of antipsychotics in the treatment for relapse prevention of schizophrenia
    Ben Makhlouf, W.
    Besbes, C.
    El Hechmi, Z.
    ANNALES MEDICO-PSYCHOLOGIQUES, 2009, 167 (10): : 774 - 778
  • [2] Physicians' and patients' involvement in relapse prevention with antipsychotics in schizophrenia
    Hamann, J
    Mischo, C
    Langer, B
    Leucht, S
    Kissling, W
    PSYCHIATRIC SERVICES, 2005, 56 (11) : 1448 - 1450
  • [3] A meta-analysis on relapse prevention in schizophrenia with new antipsychotics
    Leucht, S
    Barnes, T
    Kissling, W
    Engel, R
    Kane, J
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 21 - 21
  • [4] Long Acting Injectable antipsychotics in schizophrenia: beyond relapse prevention
    Emsley, Robin
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 320 - 321
  • [5] Optimisation of care in schizophrenia for relapse prevention with long-acting injectable antipsychotics
    Emsley, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1132 - S1133
  • [6] Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia
    Taipale, Heidi
    Tanskanen, Antti
    Luykx, Jurjen J.
    Solmi, Marco
    Leucht, Stefan
    Correll, Christoph U.
    Tiihonen, Jari
    SCHIZOPHRENIA BULLETIN, 2022, 48 (04) : 774 - 784
  • [7] Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention
    Agid, Ofer
    Foussias, George
    Remington, Gary
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (14) : 2301 - 2317
  • [8] Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention Study
    Buckley, Peter F.
    Schooler, Nina R.
    Goff, Donald C.
    Kopelowicz, Alex
    Lauriello, John
    Manschreck, Theo C.
    Mendelowitz, Alan
    Miller, Del D.
    Wilson, Daniel R.
    Ames, Donna
    Bustillo, Juan R.
    Kane, John M.
    Looney, Stephen W.
    PSYCHIATRIC SERVICES, 2016, 67 (12) : 1370 - 1372
  • [9] COST-EFFECTIVENESS OF ANTIPSYCHOTICS FOR THE TREATMENT OF RELAPSE PREVENTION FOR SCHIZOPHRENIA. THE SPANISH PERSPECTIVE
    Garcia-Agua Soler, N.
    Garcia-Ruiz, A. J.
    Martos-Crespo, F.
    Perez-Costillas, L.
    Alcalde de Hoyos, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 70 - 70
  • [10] Prevention of relapse in schizophrenia
    Lieberman, J
    Stroup, S
    Schneider, L
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (18): : 1412 - 1412
12345